We've put some small files called cookies on your device to make our site work.
We'd also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We'll use a cookie to save your choice. You can read more about our cookies before you choose.
Patient safety alert: Harm from using Low Molecular Weight Heparins when contraindicated
This alert has been issued to raise awareness of harm from using Low Molecular Weight Heparins (LMWHs) where a situation, patient’s condition, or the use of other medications mean the LMWHs could cause harm or death.